Abstract
A 61-year-old woman presented with two paraneoplastic neurologic disorders―Lambert-Eaton myasthenic syndrome (LEMS) and sub-acute cerebellar degeneration (SCD)―that antedated the diagnosis of small-cell carcinoma of the lung by 15 months. Plasmapheresis initiated before the identification of the tumor had a beneficial effect on LEMS but did not affect the SCD. Chemotherapy administered for treatment of the primary tumor was also associated with improvement of LEMS but, like plasmapheresis, had no effect on SCD. While the pathogenesis of both LEMS and SCD is thought to be mediated predominantly by humoral immune factors, a differential therapeutic response indicates that mechanisms of tissue damage or susceptibility to tissue injury, or both, differ in these two disorders.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1682-1685 |
| Number of pages | 4 |
| Journal | Neurology |
| Volume | 41 |
| Issue number | 10 |
| State | Published - Jan 1 1991 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Clinical Neurology
Cite this
}
Coexistence of lambert-eaton myasthenic syndrome and subacute cerebellar degeneration : Differential effects of treatment. / Blumenfeld, A. M.; Recht, L. D.; Chad, D. A.; DeGirolami, U.; Griffin, T.; Jaeckle, Kurt.
In: Neurology, Vol. 41, No. 10, 01.01.1991, p. 1682-1685.Research output: Contribution to journal › Article
TY - JOUR
T1 - Coexistence of lambert-eaton myasthenic syndrome and subacute cerebellar degeneration
T2 - Differential effects of treatment
AU - Blumenfeld, A. M.
AU - Recht, L. D.
AU - Chad, D. A.
AU - DeGirolami, U.
AU - Griffin, T.
AU - Jaeckle, Kurt
PY - 1991/1/1
Y1 - 1991/1/1
N2 - A 61-year-old woman presented with two paraneoplastic neurologic disorders―Lambert-Eaton myasthenic syndrome (LEMS) and sub-acute cerebellar degeneration (SCD)―that antedated the diagnosis of small-cell carcinoma of the lung by 15 months. Plasmapheresis initiated before the identification of the tumor had a beneficial effect on LEMS but did not affect the SCD. Chemotherapy administered for treatment of the primary tumor was also associated with improvement of LEMS but, like plasmapheresis, had no effect on SCD. While the pathogenesis of both LEMS and SCD is thought to be mediated predominantly by humoral immune factors, a differential therapeutic response indicates that mechanisms of tissue damage or susceptibility to tissue injury, or both, differ in these two disorders.
AB - A 61-year-old woman presented with two paraneoplastic neurologic disorders―Lambert-Eaton myasthenic syndrome (LEMS) and sub-acute cerebellar degeneration (SCD)―that antedated the diagnosis of small-cell carcinoma of the lung by 15 months. Plasmapheresis initiated before the identification of the tumor had a beneficial effect on LEMS but did not affect the SCD. Chemotherapy administered for treatment of the primary tumor was also associated with improvement of LEMS but, like plasmapheresis, had no effect on SCD. While the pathogenesis of both LEMS and SCD is thought to be mediated predominantly by humoral immune factors, a differential therapeutic response indicates that mechanisms of tissue damage or susceptibility to tissue injury, or both, differ in these two disorders.
UR - http://www.scopus.com/inward/record.url?scp=0026010604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026010604&partnerID=8YFLogxK
M3 - Article
VL - 41
SP - 1682
EP - 1685
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 10
ER -